<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02639962</url>
  </required_header>
  <id_info>
    <org_study_id>Challenge</org_study_id>
    <nct_id>NCT02639962</nct_id>
  </id_info>
  <brief_title>Characteristics of Culprit Lesion and Changes in Plaque Composition. A Dual Energy Cardiac CT Study</brief_title>
  <acronym>S-20130009</acronym>
  <official_title>Characteristics of Culprit Lesion and Changes in Plaque Composition During Follow up in NSTEMI. A Dual Energy Cardiac CT Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Identifying patients who are at risk for a future myocardial infarction, is still one of the
      biggest challenges in cardiology.

      In this study the investigators will investigate culprit lesion in patients with NSTEMI and
      the ability of cardiac CT with dual energy computed tomography (DECT) scanning to describe
      and identify plaques that may be vulnerable. The investigators will also describe changes in
      characteristic in both stable and unstable plaques during 1 year follow up of NSTEMI and a
      matching group of stable angina pectoris (SAP) patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with verified NSTEMI undergo contrast-enhanced coronary DECT before conventional
      coronary angiography (CAG), and DECT characteristics of the culprit lesion will be
      determined. All Non-culprit lesions will be observed during 2 month and 1 year follow up
      characteristics and changes in plaque composition, volume and core content will be assessed.

      Patients with SAP undergo a baseline DECT similar to NSTEMI group. Because the expected
      change in coronary plaques in SAP group is minimal, there is no need for follow up at 2
      month.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2014</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Description and characteristics of culprit lesion by DECT. (z-value)</measure>
    <time_frame>72 hours</time_frame>
    <description>measure the z-value for the culprit lesion, by marking the culprit lesion with a region of interest (ROI) and the DECT will calculate the mean z-value by mg/mm^3 in the marked ROI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Describe if the culprit lesion contains 1: soft 2: mixed or 3: calcified tissue</measure>
    <time_frame>72 hours</time_frame>
    <description>Visually description if the culprit lesion contain
1: soft tissue (dark area in the scan) 3: calc (white area) or 2: mixed (combined dark and white areas)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure the volume of the culprit lesion</measure>
    <time_frame>72 hours</time_frame>
    <description>CT software will be automatically able to measure the volume (mm3) og culprit lesion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure the remodeling index of culprit lesion</measure>
    <time_frame>72 hours</time_frame>
    <description>CT software will be automatically able to measure the remodeling index in culprit lesion (mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine the mean Z value for non-culprit plaques containing 1: soft tissue</measure>
    <time_frame>72 hours</time_frame>
    <description>measure the z-value for the culprit lesion, by marking the lesion with a ROI and the DECT will calculate the mean z-value in the marked ROI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine the mean Z value for non-culprit plaques containing 1: soft tissue</measure>
    <time_frame>2 month</time_frame>
    <description>measure the z-value for the culprit lesion, by marking the lesion with a ROI and the DECT will calculate the mean z-value mg/mm^3 in the marked ROI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine the mean Z value for non-culprit plaques containing 1: soft tissue</measure>
    <time_frame>1 year</time_frame>
    <description>measure the z-value for the culprit lesion, by marking the lesion with a ROI and the DECT will calculate the mean z-value mg/mm^3 in the marked ROI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine the mean Z value for non-culprit plaques containing 2: mixed tissue</measure>
    <time_frame>72 hours</time_frame>
    <description>z-value mg/mm^3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine the mean Z value for non-culprit plaques containing 2: mixed tissue</measure>
    <time_frame>2 month</time_frame>
    <description>z-value mg/mm^3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine the mean Z value for non-culprit plaques containing 2: mixed tissue</measure>
    <time_frame>1 year</time_frame>
    <description>z-value mg/mm^3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine the mean Z value for non-culprit plaques containing 3: calcified tissue</measure>
    <time_frame>72 hours</time_frame>
    <description>z-value mg/mm^3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine the mean Z value for non-culprit plaques containing 3: calcified tissue</measure>
    <time_frame>2 month</time_frame>
    <description>z-value mg/mm^3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Determine the mean Z value for non-culprit plaques containing 3: calcified tissue</measure>
    <time_frame>1 year</time_frame>
    <description>z-value mg/mm^3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes in non-culprit plaques during 1 year in comparison til patients with stable angina pectoris</measure>
    <time_frame>1 year</time_frame>
    <description>z-value z-value mg/mm^3</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>z value in myocardium related to culprit vessel compared to z-value in myocardium corresponded to non-culprit vessel</measure>
    <time_frame>72 hours</time_frame>
    <description>z-value z-value mg/mm^3</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">135</enrollment>
  <condition>Coronary Arteriosclerosis</condition>
  <arm_group>
    <arm_group_label>NSTEMI</arm_group_label>
    <description>patients hospitalized with NSTEMI diagnosed according to the national Danish guidelines, and are scheduled to coronary angiography.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with stable angina pectoris</arm_group_label>
    <description>Patients in this group have stable angina symptoms and had verified plaques by earlier CAG or Cardiac CT</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Cardiac CT</intervention_name>
    <description>Cardiac CT before the CAG, and follow up after 2 month and 12 month</description>
    <arm_group_label>NSTEMI</arm_group_label>
    <arm_group_label>patients with stable angina pectoris</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples for analyses as hs-CRP, Interleukins and other inflammatory agents.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with verified NSTEMI and Patients with SAP
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with NSTEMI and scheduled to CAG or patients with SAP

        Exclusion Criteria:

          -  Not suitable to undergo CT with contrast agent:

          -  Known allergy-like reactions to contrast or Claustrophobia

          -  Atrial fibrillation or significant arrhythmia judged to potentially limit quality of
             CT

          -  Known renal failure/insufficiency or s-creatinin&gt; 140 Âµmol/L.

          -  Severe/symptomatic thyrotoxicosis

          -  pacemaker
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth Egstrup</last_name>
    <role>Study Director</role>
    <affiliation>Odense University Hospital, Svendborg Research Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hussam Sheta, M.D</last_name>
    <phone>+4526821681</phone>
    <email>hussam.sheta@rsyd.dk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jess Lambrechtsen, M.D</last_name>
    <email>jess.lambrechtsen@rsyd.dk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Medical Research, OUH, Svendborg</name>
      <address>
        <city>Svendborg</city>
        <zip>5700</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hussam Sheta, MD</last_name>
      <phone>0045 63202402</phone>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2015</study_first_submitted>
  <study_first_submitted_qc>December 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2015</study_first_posted>
  <last_update_submitted>May 31, 2017</last_update_submitted>
  <last_update_submitted_qc>May 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Hussam Mahmoud Sheta</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>culprit lesion</keyword>
  <keyword>arteriosclerosis</keyword>
  <keyword>cardiac CT</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arteriosclerosis</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

